Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Higher vs. Lower Doses of Dexamethasone in Patients With COVID-19 and Severe Hypoxia

NCT04509973 is registered in ClinicalTrials.gov with Scandinavian Critical Care Trials Group as lead sponsor.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04509973 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Higher vs. Lower Doses of Dexamethasone in Patients With COVID-19 and Severe Hypoxia
Lead sponsor
Scandinavian Critical Care Trials Group
Phase
Phase 3
Overall status
Completed
Start date
August 27, 2020
Completion date
February 1, 2022
Enrollment
1,000 (actual)
Sites
53

Conditions

As the registry lists them; a condition with its own page is linked.

covid19, hypoxia